BioXcel Therapeutics Inc (BTAI) Q3 2024 Earnings Call Highlights ...

Nov 15, 2024 · BioXcel Therapeutics Inc (NASDAQ:BTAI) reported an 89% increase in net revenue for the nine months ended September 30, 2024, compared to the same period in …

CouponFollow Extension

89%
OFF

BioXcel Therapeutics Inc (BTAI) Q3 2024 Earnings Call Highlights ...

6 days from now

Nov 15, 2024 · BioXcel Therapeutics Inc (NASDAQ:BTAI) reported an 89% increase in net revenue for the nine months ended September 30, 2024, compared to the same period in …

yahoo.com

$13
OFF

BioXcel Therapeutics, Inc. (BTAI) Q3 2024 Earnings Call Transcript

6 days from now

Nov 14, 2024 · BioXcel Therapeutics had a net loss of $13.7 million for the third quarter of 2024, compared to a net loss of $50.5 million for the same period in 2023. Company used $16.3 …

seekingalpha.com

36%
OFF

BioXcel Therapeutics, Inc. (BTAI) Reports Q3 Loss, Lags ... - Nasdaq

6 days from now

Nov 14, 2024 · BioXcel Therapeutics (BTAI) delivered earnings and revenue surprises of 36% and 82.17%, respectively, for the quarter ended September 2024. Do the numbers hold clues …

nasdaq.com

36%
OFF

BioXcel Therapeutics, Inc. (BTAI) Reports Q3 Loss, Lags Revenue ...

6 days from now

Nov 14, 2024 · BioXcel Therapeutics (BTAI) delivered earnings and revenue surprises of 36% and 82.17%, respectively, for the quarter ended September 2024. Do the numbers hold clues …

zacks.com

$7
OFF

BioXcel Therapeutics Announces Pricing Of $7M Public Offering

6 days from now

1 day ago · BioXcel Therapeutics, Inc. (BTAI) Q3 2024 Earnings Call Transcript; BioXcel announces common stock and warrants offering, no amount given; BioXcel Therapeutics …

seekingalpha.com

$7
OFF

BioXcel Therapeutics Announces Pricing Of $7M Public Offering

6 days from now

BioXcel Therapeutics, Inc. (BTAI) Q3 2024 Earnings Call Transcript; BioXcel announces common stock and warrants offering, no amount given; BioXcel Therapeutics GAAP EPS of -$0.32 …

msn.com

$1.31
OFF

What To Expect From BioXcel Therapeutics Inc (BTAI) Q3 2024 …

6 days from now

BioXcel Therapeutics Inc (BTAI, Financial) is set to release its Q3 2024 earnings on Nov 14, 2024. The consensus estimate for Q3 2024 revenue is $1.31 million, and the earnings are …

gurufocus.com

$7
OFF

BioXcel Therapeutics Announces Pricing Of $7.0 Million Public …

6 days from now

1 day ago · NEW HAVEN, Conn., Nov. 22, 2024 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (the “Company”) (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial …

marketscreener.com

89%
OFF

BioXcel Therapeutics Inc (BTAI) Q3 2024 Earnings Call Highlights

6 days from now

Net Revenue for IGALMI: $214,000 for Q3 2024, compared to $341,000 for Q3 2023.Net Revenue for Nine Months Ended September 30, 2024: $1.9 million, an 89% incre. BioXcel …

gurufocus.com